先声药业(02096)完成配售现有股份及根据一般授权先旧后新认购新股份

Group 1 - The company, Sihuan Pharmaceutical (02096), announced the completion of its placement and subscription matters on September 4, 2025, and September 10, 2025, respectively [1] - A total of 121 million shares were successfully placed at a price of HKD 12.95 per share to no less than six subscribers [1] - The subscription involved the same number of shares (121 million) at the same price of HKD 12.95 per share, representing approximately 4.66% of the company's enlarged issued share capital after the completion of the subscription [1]